Annual EBIT
-$598.47 M
-$524.09 M-704.60%
December 31, 2023
Summary
- As of February 7, 2025, SMMT annual earnings before interest & taxes is -$598.47 million, with the most recent change of -$524.09 million (-704.60%) on December 31, 2023.
- During the last 3 years, SMMT annual EBIT has fallen by -$545.81 million (-1036.58%).
- SMMT annual EBIT is now -6267.86% below its all-time high of $9.70 million, reached on January 31, 2019.
Performance
SMMT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$53.80 M
+$3.48 M+6.08%
September 30, 2024
Summary
- As of February 7, 2025, SMMT quarterly earnings before interest & taxes is -$53.80 million, with the most recent change of +$3.48 million (+6.08%) on September 30, 2024.
- Over the past year, SMMT quarterly EBIT has increased by +$3.48 million (+6.08%).
- SMMT quarterly EBIT is now -250.18% below its all-time high of $35.82 million, reached on July 31, 2018.
Performance
SMMT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$185.10 M
-$35.25 M-23.53%
September 30, 2024
Summary
- As of February 7, 2025, SMMT TTM earnings before interest & taxes is -$185.10 million, with the most recent change of -$35.25 million (-23.53%) on September 30, 2024.
- Over the past year, SMMT TTM EBIT has dropped by -$35.25 million (-23.53%).
- SMMT TTM EBIT is now -1521.13% below its all-time high of $13.03 million, reached on April 1, 2019.
Performance
SMMT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SMMT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -704.6% | +6.1% | -23.5% |
| 3 y3 years | -1036.6% | -229.6% | -148.9% |
| 5 y5 years | -6267.9% | -442.0% | -553.3% |
SMMT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -704.6% | at low | -340.9% | +89.9% | -148.9% | +69.1% |
| 5 y | 5-year | -1978.0% | at low | -476.0% | +89.9% | -591.8% | +69.1% |
| alltime | all time | -6267.9% | at low | -250.2% | +89.9% | -1521.1% | +69.1% |
Summit Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$53.80 M(-6.1%) | -$185.10 M(+23.5%) |
| Jun 2024 | - | -$57.28 M(+42.0%) | -$149.85 M(+43.0%) |
| Mar 2024 | - | -$40.35 M(+19.8%) | -$104.77 M(-82.5%) |
| Dec 2023 | -$598.47 M(+704.6%) | -$33.67 M(+81.5%) | -$598.47 M(+3.0%) |
| Sep 2023 | - | -$18.55 M(+52.0%) | -$581.12 M(-0.4%) |
| Jun 2023 | - | -$12.20 M(-97.7%) | -$583.27 M(-0.7%) |
| Mar 2023 | - | -$534.05 M(+3171.4%) | -$587.18 M(+689.4%) |
| Dec 2022 | -$74.38 M(-15.8%) | -$16.32 M(-21.1%) | -$74.38 M(-12.7%) |
| Sep 2022 | - | -$20.69 M(+28.4%) | -$85.16 M(+1.3%) |
| Jun 2022 | - | -$16.12 M(-24.1%) | -$84.06 M(-8.8%) |
| Mar 2022 | - | -$21.25 M(-21.6%) | -$92.14 M(+4.9%) |
| Dec 2021 | -$88.36 M(+67.8%) | -$27.10 M(+38.3%) | -$87.82 M(+21.0%) |
| Sep 2021 | - | -$19.60 M(-19.0%) | -$72.60 M(+5.1%) |
| Jun 2021 | - | -$24.20 M(+43.0%) | -$69.08 M(+14.7%) |
| Mar 2021 | - | -$16.92 M(+42.5%) | -$60.24 M(+14.4%) |
| Dec 2020 | -$52.66 M(+82.8%) | - | - |
| Dec 2020 | - | -$11.88 M(-26.1%) | -$52.66 M(+29.1%) |
| Sep 2020 | - | -$16.08 M(+4.7%) | -$40.78 M(+17.8%) |
| Jun 2020 | - | -$15.36 M(+64.4%) | -$34.62 M(+29.4%) |
| Mar 2020 | - | -$9.34 M(-5.9%) | -$26.76 M(-5.6%) |
| Dec 2019 | -$28.80 M(-396.8%) | - | - |
| Oct 2019 | - | -$9.93 M(+32.5%) | -$28.33 M(-6.5%) |
| Jul 2019 | - | -$7.49 M(+20.5%) | -$30.29 M(-332.5%) |
| Apr 2019 | - | -$6.21 M(+32.1%) | $13.03 M(+28.1%) |
| Jan 2019 | $9.70 M(-129.6%) | - | - |
| Jan 2019 | - | -$4.70 M(-60.4%) | $10.17 M(-674.4%) |
| Oct 2018 | - | -$11.88 M(-133.2%) | -$1.77 M(-124.2%) |
| Jul 2018 | - | $35.82 M(-494.9%) | $7.32 M(-121.4%) |
| Apr 2018 | - | -$9.07 M(-45.5%) | -$34.22 M(+5.1%) |
| Jan 2018 | -$32.76 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | - | -$16.64 M(+496.2%) | -$32.57 M(+35.3%) |
| Oct 2017 | - | -$2.79 M(-51.1%) | -$24.08 M(-13.2%) |
| Jul 2017 | - | -$5.71 M(-23.1%) | -$27.74 M(-12.4%) |
| Apr 2017 | - | -$7.42 M(-9.0%) | -$31.67 M(-4.8%) |
| Jan 2017 | -$31.06 M(+7.2%) | - | - |
| Jan 2017 | - | -$8.15 M(+26.4%) | -$33.27 M(+3.2%) |
| Oct 2016 | - | -$6.45 M(-33.1%) | -$32.25 M(-5.8%) |
| Jul 2016 | - | -$9.64 M(+6.8%) | -$34.24 M(+6.7%) |
| Apr 2016 | - | -$9.03 M(+26.5%) | -$32.09 M(+10.9%) |
| Jan 2016 | -$28.98 M(+57.9%) | - | - |
| Jan 2016 | - | -$7.14 M(-15.4%) | -$28.92 M(+13.6%) |
| Oct 2015 | - | -$8.44 M(+12.7%) | -$25.47 M(+18.6%) |
| Jul 2015 | - | -$7.49 M(+27.7%) | -$21.47 M(+7.2%) |
| Apr 2015 | - | -$5.86 M(+59.1%) | -$20.03 M(+5.9%) |
| Jan 2015 | -$18.35 M(+65.9%) | - | - |
| Jan 2015 | - | -$3.68 M(-17.0%) | -$18.91 M(-2.5%) |
| Oct 2014 | - | -$4.44 M(-26.6%) | -$19.40 M(+6.5%) |
| Jul 2014 | - | -$6.05 M(+27.5%) | -$18.22 M(+49.7%) |
| Apr 2014 | - | -$4.74 M(+13.7%) | -$12.17 M(+63.8%) |
| Jan 2014 | -$11.07 M(+53.2%) | - | - |
| Jan 2014 | - | -$4.17 M(+28.0%) | -$7.43 M(+128.0%) |
| Oct 2013 | - | -$3.26 M | -$3.26 M |
| Jan 2013 | -$7.22 M(+53.5%) | - | - |
| Jan 2012 | -$4.70 M(-49.7%) | - | - |
| Jan 2011 | -$9.36 M(+1.8%) | - | - |
| Jan 2010 | -$9.19 M(-51.0%) | - | - |
| Jan 2009 | -$18.76 M(-14.2%) | - | - |
| Jan 2008 | -$21.86 M(+218.2%) | - | - |
| Jan 2007 | -$6.87 M(+113.8%) | - | - |
| Jan 2006 | -$3.21 M(+498.8%) | - | - |
| Jan 2005 | -$536.60 K | - | - |
FAQ
- What is Summit Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Summit Therapeutics?
- What is Summit Therapeutics annual EBIT year-on-year change?
- What is Summit Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Summit Therapeutics?
- What is Summit Therapeutics quarterly EBIT year-on-year change?
- What is Summit Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Summit Therapeutics?
- What is Summit Therapeutics TTM EBIT year-on-year change?
What is Summit Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SMMT is -$598.47 M
What is the all time high annual EBIT for Summit Therapeutics?
Summit Therapeutics all-time high annual earnings before interest & taxes is $9.70 M
What is Summit Therapeutics annual EBIT year-on-year change?
Over the past year, SMMT annual earnings before interest & taxes has changed by -$524.09 M (-704.60%)
What is Summit Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SMMT is -$53.80 M
What is the all time high quarterly EBIT for Summit Therapeutics?
Summit Therapeutics all-time high quarterly earnings before interest & taxes is $35.82 M
What is Summit Therapeutics quarterly EBIT year-on-year change?
Over the past year, SMMT quarterly earnings before interest & taxes has changed by +$3.48 M (+6.08%)
What is Summit Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SMMT is -$185.10 M
What is the all time high TTM EBIT for Summit Therapeutics?
Summit Therapeutics all-time high TTM earnings before interest & taxes is $13.03 M
What is Summit Therapeutics TTM EBIT year-on-year change?
Over the past year, SMMT TTM earnings before interest & taxes has changed by -$35.25 M (-23.53%)